IKEMA Trial Final Updates: Carfilzomib/Dex +/- Isatuximab in Patients With R/R MM

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos

Playback speed

10 seconds

IKEMA Trial Final Updates: Carfilzomib/Dex +/- Isatuximab in Patients With R/R MM

By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING Ecenur Güder Arslan

24 views

February 15, 2024

Comments 0

Myeloma

Real-World Treatment Patterns and Outcomes in Patients With R/R MM W…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Ö. Pektaş

10 views

Future Perspectives on the Management of Myeloma: Cure or Longterm D…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Magalhaes

38 views

Debates in Myeloma: Smoldering Myeloma Should NOT Be Treated

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

E. Terpos

29 views

Debates in Myeloma: Smoldering Myeloma Should Be Treated

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Cerchione

26 views

How I Manage Late Relapsed Myeloma With T-Cell Engaging Therapy

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Romano

14 views

Case Presentation: R/R Myeloma With Extramedullary Plasmacytoma Invo…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Yeşilaltay

13 views

MRD in the Era of Modern MM Therapies

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Magalhaes

169 views

How I Treat R/R MM With CAR-T and Bispecific Antibodies

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Cerchione

160 views

IKEMA Trial Final Updates: Carfilzomib/Dex +/- Isatuximab in Patient…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

E. Güder Arslan

24 views